Promising drug expected to become the first to slow down dementia found to not work

Promising drug expected to become the first to slow down dementia found to not work US pharma giant Eli Lilly announced a trial of 2,000 people had shown solanezumab showed no benefit for people with mild Alzheimer's, causing their share prices to take a tumble. The Daily Mail